RCGP Curriculum - 15.8 Respiratory Problems
This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more
Previous studies have shown that men are up to three times as likely as women to develop squamous cell carcinoma.
In the past, this disparity was thought to be the result of lifestyle differences since men were believed to spend more time in the sun and use less sun protection than women.
But researchers have now shown that men may be more vulnerable to cancer than women following the same amount of ultraviolet (UV) exposure.
The study tested the effect of chronic exposure to UVB light on male and female mice. UVB is the part of the light spectrum that causes sunburn and contributes to the development of skin cancer.
A group of six male and six female mice were exposed to a fixed dose of UVB radiation three times a week for 16 weeks.
The researchers found that the male mice had a worse tumour prognosis than the females.
The males developed tumours two weeks earlier than the females, they had 50 per cent more tumours and these were on average 43 per cent larger.
In addition, 39 per cent of the tumours in the male mice were malignant compared with 18 per cent in the females, and 15 per cent of tumours in the males were fully invasive squamous cell carcinomas compared to just 3 per cent in the females.
Quick search - use * for an abbreviated search, eg nico*
This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more
This section of our curriculum guide refers to statement 15.10, Skin Problems, produced by the Royal... Read more
This section of our curriculum guide refers to statement 13, Care of People with Mental Health Probl... Read more
Contributed by Dr Naila Arebi, consultant gastroenterologist, St Mark's Hospital, Harrow, and The Lo... Read more
Contributed by Dr Alan McOwan, lead clinician, Victoria Clinic for HIV and Sexual Health, London. Read more
A non-daily, low oestrogen contraceptive utilising a vaginal delivery system. Read more
Nordic Pharma has launched Siklos (hydroxycarbamide) for the prevention of recurrent painful vaso-oc... Read more
Schering-Plough has launched Bridion (sugammadex) for the reversal of neuromuscular blockade induced... Read more
Comments
Only registered users may comment. Log in now or register for a free account.